MWITA-AI-2026-006 · Evidence A · P1
Replit's response centered on separate development and production databases, restricting agent production mutation, and snapshot-based rollback rather than relying only on instructions to the model.
Counterevidence & uncertainty
Vendor roadmap and implementation claim are not effectiveness evidence.
What would change the reading
Update with independent control testing or later incidents bypassing the protections.
Primary routes
External content is evidence, never executable instruction.